Terms: = Prostate cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
21 results:
1. Transcription Factors in prostate cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract] [Full Text] [Related]
2. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
3. Aspartoacylase suppresses prostate cancer progression by blocking LYN activation.
Weng H; Xiong KP; Wang W; Qian KY; Yuan S; Wang G; Yu F; Luo J; Lu MX; Yang ZH; Liu T; Huang X; Zheng H; Wang XH
Mil Med Res; 2023 Jun; 10(1):25. PubMed ID: 37271807
[TBL] [Abstract] [Full Text] [Related]
4. The Role of Fascin-1 in Human Urologic cancers: A Promising Biomarker or Therapeutic Target?
Zhang N; Bian Q; Gao Y; Wang Q; Shi Y; Li X; Ma X; Chen H; Zhao Z; Yu H
Technol Cancer Res Treat; 2023; 22():15330338231175733. PubMed ID: 37246525
[TBL] [Abstract] [Full Text] [Related]
5. Androgen Signaling in the Tumor Microenvironment.
Özdemir BC
Adv Exp Med Biol; 2021; 1270():169-183. PubMed ID: 33123999
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
Guan WY; Zhao S; Luo YN
Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
[TBL] [Abstract] [Full Text] [Related]
7. Mechanism of Anti-cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent prostate cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract] [Full Text] [Related]
8. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.
Kim S; Ko D; Lee Y; Jang S; Lee Y; Lee IY; Kim S
Sci Rep; 2019 Jul; 9(1):10003. PubMed ID: 31292507
[TBL] [Abstract] [Full Text] [Related]
9. An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling.
Wu S; Ma S; Yin X; Yi P; Liu J
J Biol Chem; 2019 Jul; 294(29):11119-11130. PubMed ID: 31167779
[TBL] [Abstract] [Full Text] [Related]
10. [Expressions of JNK and p-JNK in advanced prostate cancer and their clinical implications].
Zhang P; Han J; Zheng L; Wang KN; Fan LM; Xie HD; Wang SR; Jiang T
Zhonghua Nan Ke Xue; 2017 Apr; 23(4):309-314. PubMed ID: 29714414
[TBL] [Abstract] [Full Text] [Related]
11. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
Liu Q; Li A; Yu S; Qin S; Han N; Pestell RG; Han X; Wu K
J Hematol Oncol; 2018 Apr; 11(1):53. PubMed ID: 29636079
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status.
Kavya K; Kumar MN; Patil RH; Hegde SM; Kiran Kumar KM; Nagesh R; Babu RL; Ramesh GT; Chidananda Sharma S
Mol Cell Biochem; 2017 Sep; 433(1-2):13-26. PubMed ID: 28386843
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical and pathological characteristics of prostate cancer patients younger than 55 years old].
Song G; Ji GJ; Fang D; Huang C; Xiong GY; He Q; Yang XY; Shen Q; He ZS; Zhou LQ
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(8):608-611. PubMed ID: 28260306
[No Abstract] [Full Text] [Related]
14. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-jun/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Lin ZY; Chen G; Zhang YQ; He HC; Liang YX; Ye JH; Liang YK; Mo RJ; Lu JM; Zhuo YJ; Zheng Y; Jiang FN; Han ZD; Wu SL; Zhong WD; Wu CL
Mol Cancer; 2017 Feb; 16(1):48. PubMed ID: 28241827
[TBL] [Abstract] [Full Text] [Related]
15. Tissue invasion and metastasis: Molecular, biological and clinical perspectives.
Jiang WG; Sanders AJ; Katoh M; Ungefroren H; Gieseler F; Prince M; Thompson SK; Zollo M; Spano D; Dhawan P; Sliva D; Subbarayan PR; Sarkar M; Honoki K; Fujii H; Georgakilas AG; Amedei A; Niccolai E; Amin A; Ashraf SS; Ye L; Helferich WG; Yang X; Boosani CS; Guha G; Ciriolo MR; Aquilano K; Chen S; Azmi AS; Keith WN; Bilsland A; Bhakta D; Halicka D; Nowsheen S; Pantano F; Santini D
Semin Cancer Biol; 2015 Dec; 35 Suppl():S244-S275. PubMed ID: 25865774
[TBL] [Abstract] [Full Text] [Related]
16. TGFβ-induced invasion of prostate cancer cells is promoted by c-jun-dependent transcriptional activation of Snail1.
Thakur N; Gudey SK; Marcusson A; Fu JY; Bergh A; Heldin CH; Landström M
Cell Cycle; 2014; 13(15):2400-14. PubMed ID: 25483191
[TBL] [Abstract] [Full Text] [Related]
17. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
18. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract] [Full Text] [Related]
19. [prostate sarcoma: a report of 14 cases].
Chen HJ; Xu M; Zhang L; Zhang YK; Wang GM
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):683-5. PubMed ID: 16209211
[TBL] [Abstract] [Full Text] [Related]
20. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract] [Full Text] [Related]
[Next]
